SearchDictionaryMobileLogin

Salvatore Cuzzocrea Selected Research

Inflammation

02/2008Sphingosylphosphorylcholine reduces the organ injury/dysfunction and inflammation caused by endotoxemia in the rat.
12/2007Vaccination with IL-6 analogues induces autoantibodies to IL-6 and influences experimentally induced inflammation.
04/2007Nitric oxide in the injured spinal cord: synthases cross-talk, oxidative stress and inflammation.
05/2006The role of the peroxisome proliferator-activated receptor-alpha (PPAR-alpha) in the regulation of acute inflammation.
03/2005Endogenous interleukin-6 enhances the renal injury, dysfunction, and inflammation caused by ischemia/reperfusion.
10/2004Inhibition of the nuclear factor-kappaB activation with pyrrolidine dithiocarbamate attenuating inflammation and oxidative stress after experimental spinal cord trauma in rats.
10/2004Noncleavable poly(ADP-ribose) polymerase-1 regulates the inflammation response in mice.
08/2004Superoxide-related signaling cascade mediates nuclear factor-kappaB activation in acute inflammation.
08/2004Tempol reduces the activation of nuclear factor-kappaB in acute inflammation.
01/2004Effect of methylguanidine in carrageenan-induced acute inflammation in the rats.
01/2004Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces acute inflammation.
01/2003Roles of nitric oxide and superoxide in inflammation.
05/2002The cyclopentenone prostaglandin 15-deoxy-Delta(12,14)-prostaglandin J(2) attenuates the development of acute and chronic inflammation.
02/2002Pharmacological actions of melatonin in acute and chronic inflammation.
01/2002Pyrrolidine dithiocarbamate attenuates the development of acute and chronic inflammation.

Articles by Research Topic

Disease

22Reperfusion Injury
10/2008 - 03/2002
21Spinal Cord Injuries (Spinal Cord Injury)
09/2008 - 10/2004
16Pancreatitis
01/2008 - 05/2002
15Colitis
09/2008 - 07/2002
15Inflammation
02/2008 - 01/2002
14Ischemia
10/2008 - 11/2002
14Shock
01/2007 - 09/2003
8Multiple Organ Failure (MODS)
05/2008 - 10/2002
7Pneumonia (Pneumonitis)
02/2008 - 08/2003
6Septic Shock (Toxic Shock Syndrome)
10/2006 - 04/2003
5Periodontitis
02/2007 - 06/2005
5Adult Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
01/2007 - 07/2002
5Pleurisy (Pleuritis)
10/2006 - 01/2003
4Arthritis (Polyarthritis)
07/2006 - 12/2003
4Experimental Arthritis
08/2005 - 10/2002
3Syndrome
11/2006 - 06/2004
2Pain (Aches)
09/2008 - 06/2004
2Endotoxemia
02/2008 - 11/2004
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2007 - 12/2004
2Rheumatoid Arthritis
08/2005 - 01/2005
2Tissue Adhesions
06/2005 - 12/2003
1Hypersensitivity (Allergy)
09/2008
1Melanoma (Melanoma, Malignant)
06/2008
1Glioma (Gliomas)
01/2008
1Edema
09/2007
1Carcinoma (Carcinomatosis)
08/2006
1Hemorrhage
05/2006

Drug/Important Bio-Agent (IBA)

15ZymosanIBA
05/2008 - 10/2002
13Caerulein (Ceruletide)IBA
01/2008 - 05/2002
10Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA
01/2007 - 06/2003
9CarrageenanIBA
02/2008 - 01/2003
8MelatoninIBA
09/2008 - 02/2002
8Nitric Oxide (Nitrogen Monoxide)FDA Link
11/2007 - 01/2003
8PPAR alphaIBA
09/2007 - 07/2002
7PPAR gammaIBA
05/2004 - 07/2002
6Peroxisome Proliferator-Activated Receptors (PPAR)IBA
05/2007 - 07/2002
6LigandsIBA
05/2007 - 07/2002
6Superoxide DismutaseIBA
06/2005 - 07/2002
5Glycogen Synthase (Synthase I)IBA
12/2007 - 05/2006
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2007 - 01/2007
5Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
02/2007 - 12/2004
5poly ADP-ribose glycohydrolaseIBA
01/2007 - 06/2004
5pyrrolidine dithiocarbamic acidIBA
06/2006 - 01/2002
5rosiglitazone (Avandia)FDA Link
05/2004 - 09/2003
5Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
02/2004 - 03/2002
4Peroxynitrous Acid (Peroxynitrite)IBA
09/2008 - 10/2006
4Thalidomide (Thalomid)FDA Link
09/2008 - 06/2005
4Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
06/2008 - 11/2004
4TNFR-Fc fusion protein (etanercept)FDA Link
05/2008 - 03/2006
4TeaIBA
10/2006 - 01/2005
4M 40403IBA
06/2005 - 07/2002
4GW 274150IBA
01/2005 - 10/2002
4Superoxides (Superoxide)IBA
08/2004 - 01/2003
3Interleukin-10 (Interleukin 10)IBA
02/2008 - 07/2002
3Interleukin-6 (Interleukin 6)IBA
12/2007 - 06/2002
3Dexamethasone (Maxidex)FDA LinkGeneric
09/2007 - 06/2005
3Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
06/2007 - 11/2003
3AG 127 (AG 126)IBA
06/2007 - 11/2003
3OxygenIBA
11/2006 - 06/2004
3Collagen Type II (Type II Collagen)IBA
07/2006 - 12/2003
38-chlorocarbochromen (AD 6)IBA
04/2006 - 03/2003
3ErythropoietinIBA
04/2006 - 12/2004
3cyclopentenoneIBA
05/2005 - 05/2002
35-aminoisoquinolinoneIBA
12/2004 - 11/2002
3MethylguanidineIBA
11/2004 - 01/2004
2palmidrolIBA
07/2008 - 09/2007
2Poly Adenosine Diphosphate RiboseIBA
06/2008 - 10/2004
2AG 556IBA
06/2007 - 11/2005
2TyrphostinsIBA
06/2007 - 11/2005
2LeukotrienesIBA
01/2007 - 01/2006
2Peroxisome ProliferatorsIBA
11/2006 - 07/2005
2tempolIBA
10/2005 - 08/2004
2CalpainIBA
04/2005 - 08/2004
2Streptozocin (Streptozotocin)FDA Link
03/2005 - 02/2004
2NADPH Oxidase (NAD(P)H oxidase)IBA
02/2005 - 10/2003
2zileuton (Zyflo)FDA Link
11/2004 - 08/2004
2M40401IBA
09/2004 - 01/2004
2calpain inhibitorsIBA
01/2004 - 10/2002
2Lipoproteins (Lipoprotein)IBA
12/2003 - 07/2003
1dihydroceramide desaturaseIBA
10/2008
1fumonisin B1IBA
10/2008
1Matrix MetalloproteinasesIBA
09/2008
1Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
09/2008
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
09/2008
1cyclopentanoneIBA
08/2008
1Protein Kinases (Protein Kinase)IBA
04/2008
1sphingosine phosphorylcholineIBA
02/2008
1infliximab (Remicade)FDA Link
01/2008
1AutoantibodiesIBA
12/2007
1Glutathione (Reduced Glutathione)IBA
08/2007
1alanylaspartic acidIBA
03/2007
1Xanthine DehydrogenaseIBA
02/2007
1Glycogen Synthase KinasesIBA
01/2007
13-aminobenzamideIBA
11/2006
1irinotecan (Camptosar)FDA LinkGeneric
08/2006
1temozolomide (Temodar)FDA Link
08/2006
1RelaxinIBA
08/2006
1AdamantaneIBA
04/2006
1Retinaldehyde (Retinal)IBA
04/2006

Therapy/Procedure

1Resuscitation
05/2006